Journey Strategic Wealth LLC Bristol Myers Squibb CO Transaction History

Journey Strategic Wealth LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$57.89 - $64.73 $5,152 - $5,760	89 Added 2.46%	3,705 $215,000
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $204,445 - $227,004	-3,209 Reduced 47.02%	3,616 $231,000
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $64,790 - $73,486	986 Added 16.89%	6,825 $473,000
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $2,054 - $2,432	30 Added 0.52%	5,839 $420,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $2 - $1,613	21 Added 0.36%	5,809 $413,000
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $12,781 - $14,076	176 Added 3.14%	5,788 $446,000
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $23,731 - $28,455	386 Added 7.39%	5,612 $410,000
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $280,270 - $326,729	5,226 New	5,226 $326,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Journey Strategic Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Journey Strategic Wealth LLC with notifications on news.